Larvol Delta - Retifanlimab-as-firstline-treatment-for-locally-recurrent-or-metastatic-squamous-cell-carcinoma-of-the-anal-canal

Zynyz (retifanlimab-dlwr) - Incyte

http://www.ncbi.nlm.nih.gov/pubmed/42674878

Adnan Antoine Shrebati; Stanislas Quesada

Sep 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next